Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2025-12-25 @ 3:28 AM
NCT ID:
NCT05224505
Eligibility Criteria:
Inclusion Criteria:
* 1\. Female and male ambulant patients
* 2\. Patients ≥ 16 years old
* 3\. Documented LGMDR9 diagnosis based on clinical presentation and genotyping confirming the FKRP gene mutations
* 4\. Moderate diaphragmatic muscle impairment
Exclusion Criteria:
* 1\. Detectable serum neutralizing antibodies against AAV9
* 2\. Cardiomyopathy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Maximum Age:
99 Years
Study:
NCT05224505
Study Brief:
Protocol Section:
NCT05224505